We are thrilled to inform you about the clinical benefits of eye tracking. Every month, we keep you updated on the latest news shared by the scientific community.
The current newsletter will emphasize the latest research about Progressive Supra Nuclear Palsy (PSP), in an attempt to echo CurePSP month of awareness. We want to express our admiration for the researchers who are enhancing the lives affected by PSP.
Enjoy the reading!
The neuroClues® Team
Researchers from Marseilles have investigated the metabolic brain correlates of ocular motor dysfunction using [18F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in early PSP.
Based on thirty-seven patients with early PSP, they found a decrease in the gain of vertical saccades correlated with reduced metabolism in Superior Colliculi (SC).
These results can contribute to the development of prodromal disease biomarkers and help providing reliable measures of disease progression for the purpose of clinical follow-up or pharmacological trials.
Researchers from the United Kingdom together with our colleague Muriel Panouillères have produced a review that aims to provide a practical approach to eye tracking that can be employed to acquire high-quality clinical data.
Based on key publications highlighting ocular motor features of each neurodegenerative disease, they built a table as seen below with ocular motor features of neurodegenerative diseases and their associated diagnostic value.